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CURRENT CLINICAL USES OF TETRACYCLINE: IS
TETRACYCLINE IN DANGER OF BECOMING
OBSOLETE AS A CLINICALLY USEFUL ANTIBIOTIC?
During the 1950s and 1960s, tetracycline was one of the
most widely used antibiotics in the United States. It had a
broad spectrum of activity against a variety of different
bacteria and was effective against intracellular and extracel-
lular pathogens (68). Tetracycline has been particularly
useful for outpatient therapy because it is relatively cheap,
can be taken orally, and has a relatively few side effects (59,
99). It does, however, have some important limitations. It is
bacteriostatic rather than bactericidal, and it cannot be used
for treatment of pregnant women or small children because it
causes depression of skeletal growth in premature infants
and discoloration of teeth in children (99). There is also a
problem with patient compliance because treatment gener-
ally involves multiple doses. Nonetheless, the combination
of low toxicity and broad spectrum of activity has far
outweighed any drawbacks tetracycline might have.
* Corresponding author.
t Present address: Department of Biochemistry, Microbiology,
and Molecular Biology, University of Maine, Orono, Maine 04469.
Today tetracycline and its various derivatives have only
limited use in treatment of clinical infections because tetra-
cycline resistance has appeared in many groups of medically
important bacteria (47). For example, as late as the 1980s
tetracycline was used to treat sexually transmitted diseases.
With the appearance of resistant strains of Neisseria gonor-
rhoeae, however, tetracycline has been discontinued as the
first line of therapy (17, 57, 60). However, oxytetracycline
and tetracycline are still used to treat nongonococcal ure-
thritis and other chlamydial infections (106). Similarly, be-
cause resistance to tetracycline is now widespread in gram-
positive cocci and has begun to appear in the mycoplasmas,
tetracycline cannot be used as the primary treatment for
bacterial infections of the lower respiratory tract (39, 51, 75,
99). Although tetracycline is used less frequently as a drug of
choice, it is still used to treat brucellosis, rickettsial infec-
tions, tularemia, early Lyme disease, and typhus (99). Doxy-
cycline is used to treat exotic diseases such as plague (99).
Additionally, tetracycline is used by dentists to treat period-
ontal disease (92) and by dermatologists to treat acne.
Nonetheless, further spread of tetracycline resistance could
render tetracycline obsolete for treatment of even these
infections.
Since tetracycline was such a useful antibiotic in the past,
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it is worth considering whether an effort should be made to
reclaim the tetracyclines as broad-spectrum antibiotics. This
has been done recently with other classes of antibiotics, e.g.,
development of ,-lactamase-resistant ,-lactam antibiotics
and new quinolones. These successes encourage optimism
about possible new derivatives of tetracycline that would be
effective against bacteria that are currently resistant. Devel-
opment of such drugs would have to be based on a thorough
understanding of the mechanisms of resistance. One goal of
this review is to survey what is known about the mode of
action of tetracycline, the various mechanisms of tetracy-
cline resistance, and regulation of resistance genes. A sec-
ond goal is to survey information about elements that
transfer tetracycline resistance genes, including some novel
types of gene transfer elements that are not plasmids. These
elements have an unusually broad host range and also carry
genes encoding resistance to macrolides, lincosamides, and
chloramphenicol. The ramification of the spread of these
elements is that other clinically significant antibiotics besides
tetracycline could become useless.
OTHER USES OF TETRACYCLINE
Antiparasitic Activity
Although tetracycline is used clinically as an antibacterial
agent, it also has activity against some protozoal parasites.
Tetracycline derivatives inhibit the growth of Giardia lam-
blia, Trichomonas vaginalis, Entamoeba histolytica, Plas-
modium falciparum, and Leishmania major (40). Tetracy-
cline derivatives differ with respect to their effectiveness in
inhibiting the growth of these parasites, and these differ-
ences are correlated with how readily the derivatives are
taken up by the parasites. The most effective derivatives are
the lipophilic ones, such as thiatetracycline, which readily
cross the cytoplasmic membrane (4). Although tetracycline
derivatives have not been used clinically as antiparasitic
drugs, such an application is conceivable in the future.
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FIG. 1. Structures of tetracycline derivatives currently used to
treat bacterial infections and structure of the new class of tetracy-
clines, dactylocyclines. The basic tetracycline structure is shown at
the bottom of the figure. In the different tetracycline derivatives,
only residues within the boxed region are changed. Accordingly,
only this region is shown for the tetracycline derivatives listed above
the conserved tetracycline structure. The moieties that are different
from those in the conserved structure at the bottom of the page are
shown in boldface type.
Additives to Livestock Feed
Oxytetracycline is widely used as an additive to livestock
feed because it stimulates weight gain in some domestic
animals (17, 22). It has been fed routinely to calves, chick-
ens, turkeys, sheep, and pigs (22). Tetracycline is also used
to improve the health and promote the growth of fish in
commercial fisheries (22). These uses of tetracycline have
been controversial because of fears that such widespread
nonclinical use would increase the incidence of tetracycline-
resistant strains. These fears are often dismissed as ground-
less by the agriculture industry because the levels of tetra-
cycline used are lower than those needed to prevent growth
of bacteria in laboratory medium. However, bacteria grow-
ing in natural environments are not growing under the
optimal conditions used to measure susceptibility to antibi-
otics in clinical laboratories, and low levels of tetracycline
could well have deleterious effects on an organism trying to
survive in a competitive, nutrient-limited environment. Ad-
ditionally, as will be described below, exposure to low levels
of tetracycline stimulates the transfer of some transmissible
elements. Thus, long-term low-level use of tetracycline
could enhance the spread of resistance transfer elements as
well as select for strains that acquire resistance genes. For
this reason, regular use of tetracyclines in animal feed should
be seriously reviewed.
STRUCTURES AND MODE OF ACTION OF
TETRACYCLINE AND ITS DERIVATIVES
Structures
The structures of tetracycline and some of its derivatives
are shown in Fig. 1. All the derivatives shown, except for the
dactylocyclines, have been used in the treatment of clinical
infections in humans. The dactylocyclines are an interesting
new group of tetracycline derivatives produced by Dactylo-
sporangium spp. (21, 111). They differ from other tetracy-
cline derivatives in that they are glycosides of tetracycline.
They appear to be effective only against bacteria carrying
tetracycline resistance genes of class K (71). However, some
tetracycline-susceptible bacteria are not inhibited by dacty-
locyclines. The failure to inhibit growth of gram-negative
bacteria and some gram-positive bacteria is most probably
due to the failure of these bacteria to take up dactylocy-
clines. In a linked transcription-translation system, dactylo-
cyclines inhibit protein synthesis at a level comparable to
that of tetracycline (71). These results are encouraging in
that they indicate the possibility that new tetracycline deriv-
atives effective against known resistance mechanisms can be
found.
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Modes of Action
Tetracycline is thought to inhibit the growth of bacteria by
entering the bacterial cell, binding to bacterial ribosomes,
and stopping protein synthesis (26). Despite years of study,
however, it is not clear exactly how tetracycline exerts its
effect. It has been shown that tetracycline binds strongly to
a single site on the 30S ribosomal subunit, and the 7S
ribosomal protein appears to form part of the binding site
(26). A highly conserved region of 16S rRNA may also be
part of the binding site (74), a feature that would explain the
broad spectrum of tetracycline. There are many weaker
tetracycline-binding sites on the ribosome, but their signifi-
cance is unclear. The direct effect of tetracycline binding to
ribosomes is that aminoacyl-tRNAs do not bind productively
to the A site on the ribosome (23). This could, by itself, be
responsible for the ability of tetracycline to inhibit bacterial
growth. However, interference with the binding of ami-
noacyl-tRNAs to the A site could also induce the stringent
response and thus trigger numerous secondary effects (16).
These secondary effects would include effects on tRNA
stability, rRNA synthesis, and amino acid metabolism, in
addition to inhibition of protein synthesis indirectly via the
stringent response (16).
Although tetracycline and most of its derivatives have
been shown to bind to ribosomes and selectively inhibit
protein synthesis, a few of the derivatives may not act this
way. Rasmussen et al. (74) have recently shown that al-
though chelocardin and thiatetracycline have good antibac-
terial activity against Escherichia coli and Bacillus subtilis,
they are very poor inhibitors of protein synthesis and appear
to bind ribosomes ineffectively or not at all. Also, unlike
other tetracyclines, they inhibit both DNA and RNA syn-
thesis as well as protein synthesis. Rasmussen et al. (74)
suggest that chelocardin and thiatetracycline may be exert-
ing their effects on the cytoplasmic membrane of the bacte-
ria. Recently, Olivera and Chopra (70) proposed that tetra-
cyclines be divided into two types on the basis of their
modes of action: those that inhibit protein synthesis (e.g.,
tetracycline, chlortetracycline, minocycline) and those that
interact with the cytoplasmic membrane (e.g., chelocardin,
anhydrotetracycline, thiatetracycline). Further work is nec-
essary to determine the exact effect of chelocardin-type
tetracyclines on the cytoplasmic membrane.
MECHANISMS OF RESISTANCE TO TETRACYCLINE
Bacteria could use three strategies to become resistant to
tetracycline: limiting the access of tetracycline to the ribo-
somes, altering the ribosome to prevent effective binding of
tetracycline, and producing tetracycline-inactivating en-
zymes (Fig. 2). All three types of resistance have been found
in clinical isolates. With the discovery of so many tetracy-
cline resistance genes in recent years, a classification
scheme had to be devised (50). The current convention is to
assign a resistance gene to a particular class on the basis of
DNA-DNA hybridization with members of that class (47).
Two genes that cross-hybridize on Southern blots under
relatively high-stringency conditions are considered to be
members of the same class. The different classes have been
given letter designations, and an attempt has been made to
keep classes with the same mechanism grouped together in
the alphabet. A list of the accepted classes of tetracycline
resistance genes is given in Table 1. Tetracycline resistance
genes have also been classified according to whether they
confer resistance to minocycline. However, as can be seen
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FIG. 2. Different mechanisms of tetracycline resistance. (A)
Susceptible bacteria accumulate tetracycline (T) to an internal
concentration high enough to allow tetracycline to bind to ribosomes
and stop protein synthesis. (B) Bacteria carrying an efflux type of
resistance gene produce a cytoplasmic membrane protein (rectan-
gular box), which pumps tetracycline out of the cell as fast as it is
pumped in. This keeps the intracellular level low enough to allow
protein synthesis to proceed. (C) Bacteria carrying a ribosome
protection type of resistance gene produce a 72-kDa cytoplasmic
protein (not shown) that somehow interacts with the ribosomes and
allows the ribosomes to proceed with protein synthesis even in the
presence of high intracellular levels of the drug. Although the effect
of the 72-kDa protein is indicated graphically by shading one of the
ribosomal subunits, it is not known whether the resistance protein
binds to the ribosome. (D) Bacteria carrying a tetracycline modifi-
cation resistance gene produce a 44-kDa enzyme that chemically
modifies tetracycline (T) to an inactive form (t), which diffuses freely
out of the cell. The enzymatic reaction requires oxygen and
NADPH. Reprinted from Molecular Microbiology (83) with permis-
sion of the publisher.
in Table 1, this is not a very useful classification tool.
Although tetracycline resistance genes from a wide variety
of bacteria have been studied and classified, there are still
reports of genes that do not cross-hybridize with any of the
genes used as hybridization probes (83). Therefore, the list
of classes in Table 1 will undoubtedly expand as the screen-
ing of tetracycline-resistant strains continues.
Limiting Tetracycline Access to Ribosomes
Reduced uptake. For tetracycline to inhibit protein synthe-
sis, it must enter the bacterial cell and bind to the ribosome.
The protonated form of tetracycline diffuses through the
cytoplasmic membrane (35, 112). However, simple diffusion
would not explain the observation that susceptible bacteria
accumulate tetracycline in their cytoplasm. McMurry et al.
(55) showed that there was an energy-dependent phase of
tetracycline uptake in addition to diffusion. Argast and Beck
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TABLE 1. Classification of known tetracycline resistance genes
Class(es)a Location Resistanceb Mechanism Protein Family and genusc Reference(s)
A to E Plasmid Tcr Mnr (A, B, E), Efflux 43 kDa, membrane Vibrio, Aeromonas, Hae- 14, 47, 49, 53, 80
Tcr Mns (C, D) mophilus, Moraxella,
Enterobacteriaceae
K Plasmid Tcr Mnr Efflux 35 kDa, membrane Staphylococcus, Bacillus 10, 34, 56
L Plasmid Tcr Mns Efflux 50 kDa, membrane Streptococcus, Entero- 7, 34, 56
coccus, Bacillus
M Chromosome,d Tcr Mnr Ribosome 72 kDa, cytoplasmic Many Gm- Gm' (see 8, 28, 38, 61, 83
plasmid protection text)
0 Plasmid, chromo- Tc' Mnr Ribosome 72 kDa, cytoplasmic Campylobacter, Strepto- 1, 76, 81, 104
somee protection coccus, Enterococcus,
Peptostreptococcus,
Mobiluncus
P Plasmid ? Efflux ? Clostridium 1, 76, 81
Q Chromosomeg Tcr Mnr Ribosome 72 kDa, cytoplasmic Bacteroides 24, 66
protection
X Plasmid Tcr Mnr Detoxifica- 44 kDa, cytoplasmic Bacteroides (cryptic) 96
tion
a Classes are defined by DNA-DNA hybridization. Classes F and N have been shown not to exist (32, 97).
b Tc, tetracycline; Mn, minocycline.
c Genera in which the resistance class is commonly found. Some resistance classes, such as K and L, have only rarely been found in genera other than those
listed. A full distribution of these classes is still not established.
d In most cases, tet(M) is found on a Tn916-type conjugative transposon (75).
e Chromosomal tet(O) determinants have so far not been shown to be self-transmissible.
f Tentative assignment based on DNA sequence analysis (81).
g Virtually all tet(Q) determinants are associated with a conjugative transposon.
(3) disputed the existence of energy-dependent uptake be-
cause they could not show saturation of tetracycline uptake,
as would be expected if a tetracycline transporter existed.
Recently, Yamaguchi et al. (112) resolved this controversy
by showing that there is energy-dependent uptake of tetra-
cycline but that it involves ApH and not a transport protein.
Tetracycline can exist in a protonated form (TH2) and a
magnesium-chelated form (THMg). The TH2 form diffuses
readily through phospholipid bilayers, whereas the THMg
form does not. Since the proportion of tetracycline in the
THMg form increases at higher pH, tetracycline is trapped
inside the bacteria as THMg because the internal pH is
higher than the external pH (112).
If diffusion were the sole mechanism of tetracycline up-
take, it would be virtually impossible for bacteria to become
resistant by blocking the movement of tetracycline across
the cytoplasmic membrane. As expected, this type of resis-
tance has not been seen. Alteration of porin proteins (e.g.,
OmpF) to limit the diffusion of tetracycline into the peri-
plasm is a possible mechanism of resistance in gram-negative
bacteria. This type of resistance, which can decrease sus-
ceptibility 6- to 18-fold, has been found in a number of
gram-negative bacteria (19, 20, 85, 86). Strains that acquire
this type of resistance also become resistant to other antibi-
otics such as 3-lactams and fluoroquinolones (19, 85, 86).
Recently, Cohen et al. (19) have shown that the multiple
antibiotic resistance of some E. coli strains is due not only to
changes in OmpF but also to changes in other outer mem-
brane proteins.
Tetracycline efflux. A second way to limit access of tetra-
cycline to ribosomes is to reduce intracellular concentrations
of tetracycline by pumping the antibiotic out of the cell at a
rate equal to or greater than its uptake. This resistance
mechanism, tetracycline efflux, is the best-studied and most
familiar mechanism of tetracycline resistance (55). The re-
sistance gene product is a cytoplasmic membrane protein
that is an energy-dependent tetracycline transporter (Fig. 2).
It is not known how this efflux protein pumps tetracycline
out of the cell, nor is it clear how this pump protects the
cells. Although efflux clearly prevents the degree of tetracy-
cline accumulation seen in susceptible cells (41), the level of
intracellular tetracycline is still relatively high compared
with levels that inhibit protein synthesis. One possible
explanation is based on the ability of tetracycline to exist in
several ionic forms (35). It is possible that one form binds
more readily to ribosomes than the other. If so, it is
conceivable that preferential pumping of the active form
might permit intracellular concentrations of tetracycline to
remain high and still allow protein synthesis. Another pos-
sibility is that the repressor protein that is coinduced with
the Tet protein acts as an initial sink for tetracycline and thus
accounts for the high internal levels (103). Alternatively,
ribosomes in living cells may for some reason be more
resistant to tetracycline than ribosomes in in vitro systems.
To date, eight classes of tetracycline efflux genes have
been identified. Classes A to E are found among the mem-
bers of the family Enterobacteriaceae and the genera Hae-
mophilus, Vibrio, Aeromonas, and Moraxella (14, 47, 53,
80). Class P, recently shown to encode a tetracycline ef-
flux-type resistance, has been found only in Clostridium spp.
(1, 81). Classes K and L have been found only in gram-
positive bacteria (10, 34, 41, 56). Initially, it appeared that
class K was most often found in Staphylococcus spp.
whereas class L was more likely to be found in Streptococ-
cus and Enterococcus spp. (10). However, recent reports of
strains of gram-positive cocci and Bacillus spp. that carry
both class K and class L resistance determinants have raised
questions about whether such a clear-cut segregation actu-
ally exists (7, 10, 34).
Although classification by DNA-DNA hybridization is
now the preferred method, efflux resistance genes have also
been classified by susceptibility to minocycline, a lipophilic
analog. Bacteria carrying resistance genes from classes A,
B, E, and K are more resistant to minocycline than are other
efflux classes, although class B exhibits much higher resis-
tance than classes A, E, and K. This difference in minocy-
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cline susceptibility indicates that there may be two func-
tional classes of efflux-based resistance, but the basis for the
difference is not understood.
Some efflux-type resistance genes are cryptic. Ives and
Bott (36) have recently shown that a region of the B. subtilis
chromosome near the origin of replication can confer resis-
tance to tetracycline when the copy number is increased.
The original strain that had this region in a single copy was
susceptible to tetracycline, whereas the strains carrying
multiple tandem duplications of this chromosomal region
were resistant. Cloning of the region on a multicopy plasmid
produced the same tetracycline resistance (36). Apparently,
expression of the gene is too low to confer resistance if the
gene is present in single copy. Sequence analysis of the gene
has shown that it belongs to class L (37). This cryptic
tetracycline efflux gene is not a general feature of B. subtilis
and is found in only a few strains (2). Although B. subtilis is
not a human pathogen, the finding of a cryptic resistance
gene in this strain raises the possibility that such genes also
occur in pathogenic species.
Efflux resistance structural genes from different classes
share considerable DNA sequence similarity. Classes A and
C share 74% DNA sequence identity, while class B shares
45% identity with class A and class C (52, 108). Similarly, the
two gram-positive efflux structural genes, tet(K) and tet(L),
share 69% DNA sequence identity (34, 44). Phylogenetic
analysis of classes A through C and classes K and L has
shown that these two families probably represent separate
lines of descent from a common ancestor. A resistance gene
from Streptomyces nimosus may represent a third lineage
(88). The tetracycline efflux proteins also share homology
with other proton-dependent transport proteins such as
sugar transporters, especially in their amino-terminal regions
(82, 88). Thus, the efflux-type resistance genes may have
evolved from transport genes.
Ribosome Protection
A less familiar type of tetracycline resistance mechanism
than tetracycline efflux is ribosome protection. Although this
mechanism is less familiar, it is probably more widespread
than tetracycline efflux (83). The resistance gene product
migrates as a 68-kDa protein on sodium dodecyl sulfate-
polyacrylamide gel electrophoresis; however, DNA se-
quence analysis reveals that the size of the protein is actually
72 kDa (12, 18, 45). This cytoplasmic protein interacts or
associates with the ribosome, making it insensitive to tetra-
cycline inhibition (Fig. 2) (11, 12, 51). The exact mode of
interaction of the resistance protein with the ribosomes is not
understood. Burdett (12) has purified one of the ribosome
protection resistance proteins (TetM) and has shown that it
can bind to ribosomes. Manavathu et al. (51) showed that in
the presence of TetM, binding of tetracycline to ribosomes is
not altered. TetM appears not to catalyze covalent modifica-
tion of a ribosomal component, as seen with erythromycin
(12, 33). The exact role of the ribosome protection protein is
still subject to much conjecture and will not be resolved until
further work has been done to determine its binding sites on
the ribosome and its role in protein synthesis.
Three classes of the ribosome protection resistance genes
have been characterized and sequenced: tet(M), tet(O), and
tet(Q) (45, 83, 93). Burdett et al. originally identified a
second class of ribosome protection genes in streptococci
and designated it class N (13), but this class has subse-
quently been shown not to exist (32). tet(M) was originally
discovered in gram-positive cocci (11) but has now been
found in a wide variety of bacteria, including Neisseria,
Haemophilus, Mycoplasma, Ureaplasma, Streptococcus,
Staphylococcus, Peptostreptococcus, Bacteroides, Kin-
gella, and Bacillus spp. (5, 9, 28, 39, 43, 61, 83). tet(O),
originally found in Campylobacter spp. (45), has now been
found in Streptococcus, Peptostreptococcus, Enterococcus,
Lactobacillus, and Mobiluncus spp. (75-77, 113). So far,
tet(Q) has been found only in Bacteroides species (24, 66).
These distributions may be misleading. Hybridization
probes for identifying tet(M) and tet(O) have been available
for some time and have been used in many surveys, whereas
probes identifying tet(Q) have only recently become avail-
able. Thus, tet(Q) may well be found in many more species
than indicated above when surveys including this class are
made of tetracycline-resistant strains.
TetM and TetO are very closely related and share 75%
amino acid sequence identity (45). TetQ is much more
distantly related and shares only 40% amino acid identity
with TetM and TetO (66). All three resistance classes confer
resistance to minocycline as well as to other tetracycline
derivatives (Table 1). An interesting feature of the ribosome
protection resistance proteins is that they share considerable
amino acid homology to elongation factor G (12, 84). This
homology is concentrated in the region of elongation factor
G that contains the GTP-binding site. Recently, Burdett (12)
has shown that TetM, like elongation factor G, has ribo-
some-dependent GTPase activity. Thus, the ribosome pro-
tection genes may have evolved from genes encoding bacte-
rial elongation factors.
Strains of bacteria carrying combinations of efflux and
ribosome protection resistance genes have been found (7,
113). Bismuth et al. (10) reported that many strains of
Staphylococcus aureus carried both tet(K) and tet(O), while
some isolates carried tet(K), tet(L), and tet(M). Roberts (76)
found various combinations of classes K, M, and 0 in some
strains of Streptococcus spp. and Peptostreptococcus spp. It
would be interesting to determine whether these resistance
classes work in synergy or whether the level of resistance is
equivalent to that conferred by a single class.
Tetracycline Inactivation
A third type of tetracycline resistance mechanism has
been discovered recently: enzymatic inactivation of tetracy-
cline (Fig. 2) (95, 96). The gene encoding this resistance was
found on two closely related Bacteroides transposons that
also carry a gene for erythromycin resistance. The tetracy-
cline resistance gene was first identified by its ability to
confer resistance on E. coli. However, the gene worked only
in aerobically grown E. coli cells and did not confer resis-
tance on anaerobically grown E. coli or on Bacteroides spp.
The gene product is a 44-kDa cytoplasmic protein that
chemically modifies tetracycline in a reaction that requires
oxygen and NADPH. Sequence analysis has shown that this
gene shares amino acid homology with a number of
NADPH-requiring oxidoreductases, particularly in the re-
gion containing the NADPH-binding site (94). This resis-
tance gene has been classified as tet(X). Originally, Park et
al. (72) had suggested the classification tet(F) (an efflux
classification) because one of the transposons, Tn4400,
conferred weak energy-dependent efflux activity on E. coli.
However, Speer and Salyers (97) showed that this efflux
activity was not linked with the resistance phenotype and
that increasing the efflux activity did not make the strain
tetracycline resistant. The finding that a strain exhibiting
tetracycline efflux was not tetracycline resistant raises fur-
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ther questions about how efflux of tetracycline confers
resistance.
The clinical significance of tet(X) is unclear. Not only does
it not confer resistance on the Bacteroides strains in which it
was originally found, but it requires such high levels of
aeration to function as a resistance factor in E. coli that it
probably could not confer meaningful levels of resistance in
the microaerophilic environment found in most sites on the
human body. At this point, the possibility cannot be ruled
out that some interaction with hemoglobin or other oxygen-
bearing molecules allows it to function in the human body. It
will be interesting to see whether further examples of this
class of antibiotic resistance gene are found in aerobic or
facultative clinical isolates.
Multiple Resistance Systems
There have been a number of reports of chromosomal
mutations that confer resistance to more than one type of
antibiotic, including tetracycline (19, 20, 25, 38, 85, 86). One
case involved some strains of N. gonorrhoeae that were
resistant to penicillins and cephalosporins but did not pro-
duce 1-lactamase. These strains were also resistant to tetra-
cycline, erythromycin, and dyes. Several genes involved in
this multiple resistance (penB, tet, mtr) were identified (38)
and appear to be able to act singly or in combination. These
genes have not yet been characterized in enough detail to
ascertain the mechanism of action.
Multiple antibiotic resistance in gram-negative enteric
bacteria has also been reported (19, 20, 25, 85, 86). George
and Levy (25) showed that exposing E. coli to increasing
concentrations of tetracycline or chloramphenicol selected
for mutations that made bacteria resistant to a variety of
antibiotics including penicillins, cephalosporins, rifampin,
nalidixic acid, and quinolones, as well as tetracycline and
chloramphenicol. Recently, a locus that appears to control
this multiple-antibiotic-resistance (MAR) system has been
identified. The locus has been designated marA (27). Loss of
marA renders E. coli unable to mutate to the multiple-
resistance phenotype. An interesting feature of marA is that
the amount of marA transcript was found to increase sever-
alfold after exposure to tetracycline or chloramphenicol, two
antibiotics that selected for mutations leading to the MAR
phenotype. One possible explanation of the MAR effect is
that an outer membrane porin is being altered in such a way
as to prevent diffusion of antibiotics through the outer
membrane. A connection between the MAR phenotype and
changes in outer membrane proteins has been noted (19, 20,
85, 86). MAR mutants appear to have an active efflux system
(25), but the actual mechanism of this multiple resistance has
not yet been determined.
REGULATION OF TETRACYCLINE
RESISTANCE GENES
Many tetracycline resistance genes are regulated. The
best-understood type of regulation is that of tet(B) the gene
found on TnlO (9, 29). tet(B) is transcribed divergently
from tet(R), a gene encoding the repressor protein TetR(B).
(The convention for naming regulatory proteins is to use
R and give the class of the structural gene in parentheses.)
The two promoters are overlapping and share a common
regulatory region (30, 31, 42). In the absence of tetracy-
cline, TetR(B) binds as a dimer to two operator sites. This
binding blocks transcription of both the tet(B) and tetR(B)
genes. The affinity of TetR(B) for tetracycline is much
greater than its affinity for the operator sites. When tetracy-
cline enters the cell, it binds TetR(B) and changes the
conformation of TetR(B) so that it no longer binds to the
operator. Thus, transcription of the resistance gene is dere-
pressed. Transcription of tet(R) is also derepressed, but
TetR(B) inhibits transcription only when there is no longer
enough tetracycline present to bind all of the repressor in the
cell.
A different type of regulation is seen in the gram-positive
efflux genes tet(K) and tet(L) (37). This mechanism, attenu-
ation, is similar to the mode of regulation described previ-
ously for erythromycin resistance genes (33). The mRNA
transcript, which starts 123 bp upstream of the start codon of
the tet gene, contains two ribosome-binding sites (RBS).
Ribosomes binding to the first RBS, RBS1, translate a short
peptide that ends shortly before the second RBS, RBS2. If
RBS2 is exposed, ribosomes bind at this site and begin to
translate the resistance gene. The region of mRNA contain-
ing RBS2 can form one of two stem-loop structures. One of
these structures covers RBS2 and prevents the ribosomes
from binding. This is the structure that is thought to form in
the absence of tetracycline. The ribosome binds to RBS1 and
moves rapidly along the mRNA until it encounters a stem-
loop structure that blocks RBS2 and the start for the Tet
protein (34, 41). When tetracycline is present, however,
ribosomes stall and thereby allow the formation of an
alternate, more stable stem-loop structure that does not
mask RBS2. Under these conditions, the resistance gene is
translated (34, 41).
Recent work has focused on the mechanism of regulation
of ribosome protection genes. Expression of the Bacteroides
gene tet(Q) is regulated by tetracycline at the level of
transcription (100). However, sequence analysis of the up-
stream region has shown that there is no repressor gene and
no stem-loop structures such as those usually seen upstream
of the genes regulated by attenuation (65). Thus, the regula-
tion of tet(Q) is probably different from that of the efflux
genes. There is some disagreement about whether expres-
sion of tet(M) and tet(O) is regulated. Wang and Taylor (110)
have identified a 300-bp region upstream of the tet(O) coding
region that is essential for full expression of the gene. They
describe expression of tet(O) as constitutive. However,
Burdett (12) reported that the amount of TetM increased
when streptococci were exposed to tetracycline. Also, Nesin
et al. (63) reported that preexposure of an S. aureus strain
carrying tet(M) to subinhibitory concentrations of tetracy-
cline not only doubled the tetracycline MIC but also caused
an increase in the level of tet(M) mRNA transcripts seen on
Northern (RNA) blots. Subsequently, Su et al. (102) re-
ported tetracycline enhancement of tet(M) transcription
from Tn916. They detected a short transcript as well as the
full-length transcript in Northern blots. Because they de-
tected stem-loop structures in the region upstream of the
structural gene, they suggested that TetM expression was
regulated by attenuation. Thus, it seems clear that expres-
sion of tet(M) is regulated, although the precise mechanism
is still uncertain. Since tet(M) and tet(O) have virtually
identical upstream regions, they would be expected to ex-
hibit the same type of regulation. The sequence of the
upstream region of tet(Q) differs considerably from those of
the upstream regions of tet(M) and tet(O), so that the
regulation of tet(Q) could well be different from that of
tet(M) and tet(O).
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TESTING FOR SUSCEPTIBILITY TO TETRACYCLINE
Because many tetracycline resistance genes are regulated,
it may be desirable to include an induction step in the
procedure for testing susceptibility to tetracycline. Nesin et
al. (63) found that preexposure of an S. aureus strain
carrying tet(M) to low levels of tetracycline increased the
tetracycline MIC from 25 to 60 ,ug/ml. No systematic studies
of the impact of preexposure to tetracycline on MIC have
been performed, and the effect would probably vary from
species to species. On the basis of experience with other
inducible resistances, it is possible that such an induction
step is not required to obtain accurate MICs, because failure
to induce usually results in a lag in growth rather than in a
failure to grow. Thus, if incubation times are relatively long,
the difference in MICs between induced and uninduced
cultures is not great. However, the effect of eliminating the
induction step could well be substantial for some types of
bacteria, particularly those that are difficult to grow. For this
reason, a comparison of induced versus uninduced inocula
should be done when procedures for MIC testing on any new
group of bacteria are being established.
A little-appreciated problem in tetracycline susceptibility
testing is that different genera of bacteria have different basal
levels of susceptibility to tetracycline. For example, tetra-
cycline MICs for E. coli strains not harboring resistance
genes are generally 1 to 2 ,g/ml. In comparison, MICs for
Haemophilus strains not harboring resistance genes are
usually 10-fold lower than those for E. coli. Thus, a resis-
tance gene in E. coli that increases the tetracycline MIC
50-fold will give MICs of at least 50 ,ug/ml, whereas a gene
that produces a similar increase in the MIC for Haemophilus
may give an MIC of only 4 to 8 ,ug/ml. To make matters
worse, there can be considerable strain-to-strain variability
in MICs associated with the same gene in different organ-
isms. This kind of variability has been seen in Corynebacte-
nium strains (79). Much of the variability is found in the
intermediate range of susceptibility. One possible reason for
the variability in MICs is that the medium has not been
sufficiently adjusted to support optimum growth for all
strains of the genus. Other reasons include the presence of
cryptic genes that can be activated during exposure to
tetracycline or resistance genes whose expression has been
increased by insertion of an insertion element upstream of
the gene. Further investigation of this phenomenon is
needed. It is clear that the susceptibility and resistance
breakpoints must be established separately for each genus
and species and not simply inferred from results obtained
with a few well-studied species.
A potential solution to the problems described above,
which reflect difficulties in interpreting the phenotypic
expression of a resistance gene, is to base resistance deter-
minations on the presence of a gene rather than on the level
of its expression in laboratory medium. There are now
enough DNA sequences of different genes representing
efflux and ribosome protection types of resistances to permit
the design of polymerase chain reaction (PCR) primer sets
on the basis of DNA sequences conserved in the different
classes of resistance genes that would recognize virtually all
efflux or all ribosome protection genes. At present, PCR
technology would be cost prohibitive in the clinical setting
and the assay does not always yield interpretable data.
Recently, however, Tokue et al. (105) reported the use of
PCR to detect methicillin-resistant S. aureus. In this study,
clinical isolates were used to test for the presence of methi-
cillin resistance by both MIC and PCR techniques. Although
the study proved PCR to be effective in detecting methicillin-
resistant strains that MIC assays failed to detect, PCR
technology has not been sufficiently developed for routine
use in hospitals and clinical-testing laboratories. Whether
PCR will prove as powerful a tool in the detection of
resistant strains as it has in the diagnosis of diseases such as
Lyme disease has yet to be determined (105).
HAVE WE SEEN IT ALL? PROSPECTS FOR
APPEARANCE OF NEW TYPES OF
TETRACYCLINE RESISTANCE
Each of the three well-characterized types of resistance
gene (efflux, ribosome protection, and antibiotic inactiva-
tion) appears to have evolved from housekeeping genes such
as those encoding transport proteins (efflux), elongation
factors (ribosome protection), and oxidoreductases (antibi-
otic inactivation). Mutations that affect porins should prob-
ably be added to this list, since porins could be considered to
have a housekeeping function in the gram-negative bacteria.
In the case of efflux- and ribosome protection-type resis-
tance genes, it is clear from the sequence divergence seen
when different classes of genes are compared that these
genes have been evolving for a long time. If other house-
keeping genes could evolve into tetracycline resistance
genes, we should have seen them by now, particularly since
information on tetracycline resistance genes from virtually
all known phylogenetic groups of bacteria that cause human
disease is now available. However, it is important to remem-
ber that human clinical isolates represent only a small
portion of bacteria in nature. Thus, surveys of bacteria
isolated from sites other than the human body could con-
ceivably uncover new resistance mechanisms.
The tetracycline-producing bacteria must protect them-
selves from the antibiotic they produce, and antibiotic resis-
tance genes are frequently linked to genes for antibiotic
production (109). Since there has presumably been a strong
continuous selection for resistance genes in tetracycline-
producing bacteria, the variety of resistance genes found in
these bacteria should give an indication of the possible
varieties of tetracycline resistance mechanisms that might
arise as a result of tetracycline selection. Streptomyces
rimosus (an oxytetracycline producer) has two types of
tetracycline resistance genes (69). One type appears to
encode a resistance similar to TetM, TetO, and TetQ. That
is, the resistance protein is loosely associated with ribo-
somes and protects them from tetracycline without any
apparent covalent modification. A second gene encodes a
protein that is responsible for decreased accumulation of
tetracycline and is probably an efflux-type resistance pro-
tein. In Streptomyces aureofaciens (a producer of tetracy-
cline and chlortetracycline), ribosomes appear to be cova-
lently modified (58). Thus, it is possible that a covalent-
modification type of ribosome protection mechanism will
eventually be seen in clinical isolates. It is interesting that
tetracycline producers have oxidoreductases similar to TetX
that participate in the biosynthetic pathway, although these
have not been linked to protection of the antibiotic producer.
TRANSFER OF TETRACYCLINE RESISTANCE GENES
AMONG HUMAN CLINICAL ISOLATES
Types of Gene Transfer Elements
Surveys of tetracycline-resistant strains of bacteria have
repeatedly found the same efflux or ribosome protection
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genes in many different bacterial genera. These findings
suggest that extensive horizontal transfer of these resistance
elements has occurred. Conjugation is probably responsible
for most of this horizontal transmission. Two types of
conjugal element have been described: conjugative plasmids
and conjugative chromosomal elements called conjugal
transposons (83).
Efflux genes and ribosome protection genes have been
found both on plasmids and in the chromosome. Conjugative
plasmids have undoubtedly contributed to the spread of
efflux gene classes A to E within the gram-negative bacteria
and of classes K and L within the gram-positive bacteria (34,
44, 46). tet(M) has been found on plasmids in Neissenia spp.
but is also frequently located in the chromosome of other
bacteria (77, 78). The chromosomal tet(M) gene is frequently
transmissible, and transmissible chromosomal tet(M) deter-
minants are associated with conjugative transposons (87,
107). The tet(M)-carrying conjugative transposons have a
remarkably wide host range and can transfer from gram-
positive to gram-negative bacteria as well as between gram-
positive bacteria (8). Chromosomal tet(Q) determinants are
frequently transmissible and have so far been found exclu-
sively on conjugative transposons (89).
Since conjugative transposons have only recently been
studied in detail and are not as familiar as conjugative
plasmids, a summary of their properties will be given here.
Three types of conjugative transposons have been charac-
terized. Their structures are compared with that of TnlO in
Fig. 3. TnJO and most other transposons are flanked by large
(1- to 1.5-kb) repeats (insertion sequences). This is not the
case with the conjugative transposons. The only identity at
the ends is a short, imperfect inverted repeat less than 15 bp
long (6, 73). It is unfortunate that the conjugative chromo-
somal elements have been called transposons and in many
cases have been given transposon designations (e.g., Tn916),
because the so-called conjugative transposons have almost
nothing in common with transposons such as TnlO. Aside
from the fact that the conjugative transposons, unlike TnlO,
are capable of precise excision and do not have large flanking
repeats, they do not duplicate the target site when they insert
(6, 15, 73). In fact, they have more in common with the
lambdoid phages than with transposons such as TnlO (73).
Conjugative transposons range from 16 to more than 150
kb in size. Members of the Tn916 family, which were
originally found in streptococci, are the smallest examples
(87). Much larger conjugative transposons are found in
Streptococcus pneumoniae and Bacteroides species (6, 46,
62, 89). The streptococcal conjugative transposons carry
tet(M), and the Bacteroides conjugative transposons carry
tet(Q). The larger streptococcal elements, such as Tn3701,
are composite elements that contain an inserted copy of a
Tn916-type transposon (4, 46). Another example of a com-
posite element has recently been found in Bacteroides spp.
A 150- to 200-kb Bacteroides conjugative transposon (Tcr
Emr_12256) consists of one of the smaller (70- to 80-kb)
Bacteroides transposons inserted into another element (6).
Many of the conjugative transposons carry not only tet(M)
or tet(Q) but also genes encoding resistance to macrolides
and lincosamides (erm) and resistance to chloramphenicol
(cat) (4, 89).
The conjugative transposons can do more than transfer
themselves from the chromosome of a donor to the chromo-
some of a recipient. First, they can insert into plasmids
(107), making the plasmid self-transmissible. Second, conju-
gative transposons in the chromosome can mobilize coresi-
dent plasmids in trans (62, 89). Recently, the Bacteroides
conjugative transposon was shown to be capable of excising
discrete, unlinked chromosomal segments (101) and trans-
ferring these segments to a recipient, where the segments
were integrated into the chromosome (6). Although the
excised segments thus far studied appear to be cryptic, some
may turn out to carry resistance genes. Thus, the presence of
a conjugative transposon in a bacterial strain makes that
strain capable of transferring not only resistance genes on
the conjugative transposon but also resistances located on
other elements such as plasmids and chromosomal segments
that are not self-transmissible.
An important feature of conjugative transposons is that
they do not exclude other conjugative transposons or plas-
mids (67). Therefore the same strain can acquire multiple
conjugative transposons and plasmid combinations. This
observation should be kept in mind by those who screen
clinical isolates for different tetracycline resistance classes.
Regulation of Transfer Genes by Tetracycline
An interesting feature of the Bacteroides conjugative
transposons is that their transfer frequency is enhanced 100-
to 1,000-fold by preexposure to tetracycline (100). This
characteristic may not be limited to the Bacteroides ele-
ments. Torres et al. (107) have now found that transfer of
Tn925, one of the Tn916 family of tet(M) conjugative trans-
posons, is enhanced by preexposure to tetracycline, al-
though the enhancement was only 10-fold. Stevens et al.
(100) recently showed that tet(Q) is the first gene in a
three-gene operon that contains two genes with amino acid
homology to components of known two-component regula-
tory systems. This three-gene operon appears to be essential
for transfer and other activities of the Bacteroides elements.
Thus, tet(Q), unlike most resistance genes found on conju-
gative elements, is not simply a hitchhiker that has been
picked up by the self-transmissible element but instead
appears to play an important role in the regulation of element
transfer. It is possible that the failure to detect the transfer of
chromosomal tet(O) genes has been because transfer is
tetracycline inducible (45).
Most investigations to date have focused on transfer of the
conjugative transposons themselves or on cotransfer of
discrete elements such as plasmids. Torres et al. (107) have
shown that Tn925 was able to transfer chromosomal genes
from one B. subtilis strain to another. The interesting feature
of this transfer was that the transferred chromosomal genes
were not closely linked to the Tn925 insertion in the donor
but were scattered around the B. subtilis chromosome. On
the basis of this observation, Torres et al. (107) suggested
that mating between donor and recipient actually involves a
type of cell fusion rather than formation of a selective pore
as seen in plasmid conjugation. These results raise the
interesting possibility that the tetracycline resistance conju-
gative transposons are capable of transferring chromosomal
virulence factors as well as antibiotic resistances, but such
transfer has not yet been shown.
THE NORMAL MICROFLORA AS A RESERVOIR FOR
RESISTANCE GENES
It has long been suspected that the bacteria that normally
colonize the human body (the resident microflora) could act
as reservoirs for resistance genes, which could then be
transferred to pathogens during their temporary colonization
of the same site (48). tet(M), the resistance determinant
found in many pathogens that transiently colonize the human
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FIG. 3. Structures of known conjugative transposons compared with that of TnlO. TnlO and other well-studied transposons are flanked
by large direct or inverted repeats (heavy arrow) called insertion sequences (IS). Wavy lines on either side indicate the replicon (chromosome,
plasmid) into which the transposon is inserted. In TnlO, the resistance gene (tetB) and its repressor (tetR) are transcribed divergently from
the same promoter-operator region (thin arrows). The Tn916 class of conjugative transposon does not have large repeats at the ends (indicated
by different patterns) but rather has short 15-bp imperfect indirect repeats (*) (18). These conjugative transposons all carry tet(M) and
sometimes other resistance genes (Xr), where X can be erythromycin or kanamycin. The larger streptococcal elements, exemplified by Tn3701
and Tn5253, also appear not to have large repeats at the end. They have a composite structure with an inserted Tn916 type of conjugative
transposon and frequently carry a cat gene as well as other resistance genes. Most Bacteroides elements so far studied resemble Tcr Emr-DOT
(shown here). Like Tn916, they have short, imperfect inverted repeats at their ends (*) but not large direct or indirect repeats (6). All these
elements carry tet(Q), and many carry ermF and tet(X). The tet(X) gene is cryptic in this case. One Bacteroides element, Tcr Emr-12256,
consists of a Tcr Emr-DOT-type element inserted into another element. Self-transfer means the ability to excise from the donor chromosome,
transfer to a recipient, and integrate into the recipient chromosome. Plasmid mobilization means that the element can mobilize coresident
plasmids in trans.
body, is also found in Enterococcusfaecalis, a component of
the normal microflora of the colon, and in S. aureus and
streptococci that colonize the oropharynx. tet(O) has been
found in Lactobacillus strains that colonize the vaginal tract.
Thus, it is possible that horizontal transfer between mem-
bers of the normal microflora and pathogens occurs readily
in the various microniches provided by the human body.
Despite the importance of transfer between members of the
resident microflora and pathogens that transiently colonize
the human body, few studies of the incidence of tet genes in
the normal microflora have been done.
To date, the most comprehensive study of common com-
mensals has been a survey in which Roberts and Hillier (77)
tested 71 random Peptostreptococcus isolates from pregnant
women, who had not taken any antibiotic for 2 weeks prior
to sampling, for the presence of different tetracycline resis-
tance determinants. Ninety-six percent of the strains were
resistant. Most of this resistance was associated with TetM,
but classes K, L, and 0 were also detected. The discovery in
common commensals of the same resistance genes now
found frequently in many genera of pathogenic bacteria
thought to have humans as their only host provides strong
evidence that the normal microflora does in fact exchange
DNA with pathogens that transiently colonize the same site.
Recently, transfer of the resistance plasmid pAMP1 between
Enterococcus and Lactobacillus spp. was shown to occur in
the gastrointestinal tract of mice (54). This finding provides
further evidence that conjugal transfer of broad-host-range
resistance transfer elements can actually occur under condi-
tions existing in a mammalian host.
9.3
+ +
+
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TRANSFER OF RESISTANCE GENES BETWEEN THE
NORMAL MICROFLORAS OF HUMANS AND
DOMESTIC ANIMALS
It is perhaps not surprising that extensive transfer of
tetracycline resistance genes has occurred between different
species of bacteria that colonize the human body either
permanently as members of the normal microflora or tran-
siently as pathogens, because these bacteria are in frequent
contact within the same host. Also, the widespread use of
tetracycline for treatment of human diseases, even when it is
administered in subtherapeutic doses, tends to select for
strains that have acquired resistance genes. It is not so
obvious whether the use of tetracycline in animal feed might
favor the rise of tetracycline resistance genes in animals and
the subsequent transfer of these genes to human pathogens.
Reports of antibiotic-resistant Salmonella strains that were
apparently transmitted from farm animals to humans have
appeared (98), but until recently there was no evidence that
transfer of genes between bacteria that normally colonize
humans and bacteria that normally colonize domestic ani-
mals had occurred. The most insidious type of transfer
would be transfer between the normal microflora of humans
and the normal flora of animals, because once a gene on a
transmissible element has entered the normal microflora of
humans, it has the potential to be spread to any pathogen
that comes into contact with the microflora. Thus, the spread
of resistance genes would not be confined to zoonoses such
as Salmonella spp., which colonize both domestic animals
and humans.
It has now been shown that naturally occurring conjuga-
tive transposons from the Bacteroides fragilis group can
transfer to Prevotella ruminicola, a species found in high
numbers in the normal microflora of the rumen of cattle and
sheep, under laboratory conditions (91). Similarly, a trans-
missible plasmid originally found in a strain of P. ruminicola
isolated from the rumen of sheep could be transferred to
members of the B. fragilis group under laboratory condi-
tions. Evidence that this type of transfer may actually have
occurred in nature came from the finding that the tetracy-
cline resistance gene on the plasmid from P. ruminicola was
virtually identical to the tet(Q) gene found on the Bacteroi-
des conjugative transposon (90). Recently, the tet(Q) gene
from the Bacteroides conjugative transposon has also been
found in some other Prevotella strains isolated from animals
in a different location (64). Finding the same gene in two
distantly related species strongly suggests that horizontal
transfer has occurred in the recent past.
CONCLUSIONS AND RECOMMENDATIONS
The desirable properties of the tetracyclines make them
prime candidates for future rehabilitation. The recent dis-
covery of a new class of tetracycline derivatives, the dacty-
locyclines, indicates that despite the limited number of
groups on the tetracycline molecule that can be modified
without abolishing activity, new classes of tetracycline may
yet be found. The findings by Rasmussen et al. (74), which
indicate that some tetracycline derivatives may not act by
stopping protein synthesis, raise further hope that new
tetracycline derivatives may be forthcoming. Presumably,
the ribosome protection type of tetracycline resistance genes
would not confer resistance to tetracycline derivatives that
did not act at the level of the ribosome. The mechanisms of
tetracycline efflux and ribosome protection are still not fully
understood, and further work is required to elucidate them.
Once they are fully understood, the information could aid in
the design of new tetracycline derivatives. In particular, it
would be of interest to know whether only one form of
tetracycline, e.g., the zwitterionic form, is effective in stop-
ping protein synthesis and, if so, whether this form is
preferentially ejected by the efflux pump. Such a preference
would explain why efflux pumps confer resistance without
dropping the intracellular tetracycline concentration to very
low levels.
Oddly enough, there does not seem to be a standard
battery of resistance classes that is used to evaluate new
antibiotics. For example, the dactylocyclines have so far
been tested only on strains carrying efflux resistances. The
much more widespread and problematic ribosome protection
resistance genes were not included. Any new tetracyclines
should be tested at a minimum on strains carrying classes A
(or B), C (or D), K, L, M, and 0. It would also be wise to test
new tetracycline derivatives for effectiveness against strains
carrying the Streptomyces gene that appears to covalently
modify ribosomes, since this type of resistance might appear
in clinical isolates in the future. Finally, new tetracycline
derivatives should be tested for ability to induce resistance
gene expression and transfer frequency of the conjugative
chromosomal elements. Even if new antibiotics are effective
against strains carrying tet(M), they could still contribute to
the transfer of resistances linked to tet(M) on conjugative
transposons if they induce transfer.
Tetracycline resistance determinants may prove to be
useful tools for studying transmission of resistance genes
from resistant microfloras to pathogens and from one patho-
genic species to another, since some tetracycline resistance
genes and the conjugative elements that carry them have
extraordinarily broad host ranges. The genes can thus be
monitored in a variety of different types of bacteria. Also,
since more than one conjugative element and more than one
resistance class can coexist in a single strain, the incidence
of multiple transfer events to the same strain can be inves-
tigated. Several questions must be answered. How wide-
spread is carriage of known tetracycline resistance genes in
nonhospitalized people, and which genes are most common?
Although there have been a number of surveys of the
incidence of tetracycline resistance in these populations (48),
the resistance genes themselves have rarely been identified.
Do low levels of tetracycline in foods, especially fish, affect
the number of resistant bacteria in the resident microflora? Is
there any evidence that conjugative transposons, whose
transfer is stimulated by tetracycline, spread more or less
frequently than elements exhibiting constitutive transfer?
Does cessation of exposure to tetracycline reduce the resis-
tance level of the resident microflora?
The advisability of continuing to add tetracycline to live-
stock and fish feed must be reevaluated, especially if new
tetracycline derivatives return the tetracycline family to the
category of broad-spectrum antibiotics. There is no point in
losing tetracycline twice. Unfortunately, there is still rela-
tively little information on which to base such a reevalua-
tion. For example, there is no information about the inci-
dence of resistant bacteria in animals being fed tetracycline.
It is also not clear to what extent bacteria colonizing animals
that are not directly receiving tetracycline-supplemented
feed will be affected by feeding tetracycline to subpopula-
tions of animals on the same farm. Conceivably, aerosols
may spread tetracycline more widely than is now realized. In
particular, there is virtually no information on the effect of
long-term exposure to low levels of tetracycline on the
incidence and spread of antibiotic resistance genes. On the
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positive side, recent advances in knowledge about some of
the numerically predominant groups of bacteria in the nor-
mal microflora of animals now make it possible to address
such questions on a scientific basis.
Even if tetracycline becomes obsolete as a clinically useful
antibiotic, tetracycline resistance transfer elements will con-
tinue to be a cause for concern because they can carry other
resistance genes. Also, it is interesting that tetracycline is
one of the antibiotics that selected for the multiple-resistance
phenotype (MAR) described by George and Levy (25).
Tetracycline exposure could increase resistance to other
antibiotics by this route as well.
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